Old Web
English
Sign In
Acemap
>
authorDetail
>
Amanda Natsuhara
Amanda Natsuhara
University of California, San Diego
Pembrolizumab
Medicine
Cetuximab
Head and neck squamous-cell carcinoma
Oncology
4
Papers
28
Citations
0.00
KQI
Citation Trend
Filter By
Interval:
1900~2024
1900
2024
Author
Papers (2)
Sort By
Default
Most Recent
Most Early
Most Citation
No data
Journal
Conference
Others
A phase 1b study of personalized neoantigen vaccine plus pembrolizumab in adults with advanced cancer.
2021
Journal of Clinical Oncology
Aaron M. Miller
Zeynep Koşaloğlu-Yalçın
Luise Westernberg
Leslie Montero
Milad Bahmanof
Angela Frentzen
Ashmitaa Logandha Ramamoorthy Premlal
Jason A. Greenbaum
Grégory Seumois
Roxanne Habbaba
Amanda Natsuhara
Kim McConnell
Elaine Eng
Alessandro Sette
Bjoern Peters
Stephen P. Schoenberger
Ezra E.W. Cohen
Show All
Source
Cite
Save
Citations (0)
An open-label, non-randomized, multi-arm, phase II trial evaluating pembrolizumab combined with cetuximab in patients (pts) with recurrent/metastatic (R/M) head and neck squamous cell carcinoma (HNSCC): updated results of cohort 1 analysis
2020
International Journal of Radiation Oncology Biology Physics
Assuntina G. Sacco
Ruifeng Chen
Debanjali Ghosh
Francis P. Worden
Deborah J. Wong
Douglas Adkins
Paul L. Swiecicki
Wanxing Chai-Ho
Emily Pittman
Karen Messer
Kathryn A. Gold
Gregory A. Daniels
Brian Sutton
Amanda Natsuhara
Ezra E.W. Cohen
Show All
Source
Cite
Save
Citations (7)
1